Nucleic Acid Isolation and Purification Market by Product (Kit, Reagent, Instrument), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, miRNA), Application (Drug Discovery, Precision Medicine), End User (Academic) - Global Forecast to 2025

核酸分離・精製の世界市場予測(~2025):製品別、方法別、種類別、用途別、エンドユーザー別

◆タイトル:Nucleic Acid Isolation and Purification Market by Product (Kit, Reagent, Instrument), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, miRNA), Application (Drug Discovery, Precision Medicine), End User (Academic) - Global Forecast to 2025
◆商品コード:BT 2398
◆調査・発行会社:MarketsandMarkets
◆発行日:2020年6月3日
◆ページ数:192
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:化学
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥529,650見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥711,550見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥872,050見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社は核酸分離・精製の世界市場が2020年32億ドルから2025年48億ドルまで、年平均8.9%成長すると見込んでいます。本調査レポートでは、核酸分離・精製の世界市場を詳細に調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別(キット、試薬、器具)分析、方法別分析、種類別分析、用途別分析、エンドユーザー別分析、地域別分析、競争状況、会社評価マトリックス&会社プロファイル、企業概要などを含め、提供しております。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・核酸分離・精製の世界市場規模:製品別(キット、試薬、器具)
・核酸分離・精製の世界市場規模:方法別
・核酸分離・精製の世界市場規模:種類別
・核酸分離・精製の世界市場規模:用途別
・核酸分離・精製の世界市場規模:エンドユーザー別
・核酸分離・精製の世界市場規模:地域別
・競争状況
・会社評価マトリックス&会社プロファイル
・企業概要

“The nucleic acid isolation and purification market is projected to grow at a CAGR of 8.9% during the forecast period (2020–2025).”
The global nucleic acid isolation and purification market is projected to reach USD 4.8 billion by 2025 from USD 3.2 billion in 2020, at a CAGR of 8.9% during the forecast period. The major factors driving the growth of the market include increasing R&D activities as well as technological advancements and increasing automation. However, the high cost of automated instruments is expected to hinder the growth of the market.

“The instruments segment will grow at the highest rate during the forecast period.”
On the basis of product, the nucleic acid isolation and purification market is segmented into kits, reagents, and instruments. In 2019, kits were the largest product segment in the market. Growth in this market can be attributed to the continuous focus of key market players on developing and launching new and advanced kits. However, the instruments segment is expected to grow at the highest rate during the forecast period.

“By type, the plasmid DNA isolation and purification segment accounted for the largest share of the nucleic acid isolation and purification market in 2019.”
On the basis of type, the global nucleic acid isolation and purification market is segmented into plasmid DNA isolation and purification, total RNA isolation and purification, circulating nucleic acid isolation and purification, genomic DNA isolation and purification, messenger RNA isolation and purification, microRNA isolation and purification, PCR cleanup, and other nucleic acid isolation and purification types. The plasmid DNA isolation segment accounted for the largest share of the nucleic acid isolation and purification market in 2019. The large share of this market segment can be attributed to the wide use of purified plasmid DNA in a variety of downstream applications, such as PCR, sequencing, expression of proteins, gene therapy, and transfection.

“The market in the Asia Pacific is projected to witness the highest growth rate during the forecast period (2020–2025).”
North America accounted for the largest share of the nucleic acid isolation and purification market in 2019. Significant R&D spending in biotechnology and pharmaceutical companies, the large size of the biotechnology industry, technological advancements, and government support in the region are the key factors driving the growth of the nucleic acid isolation and purification market in North America. On the other hand, the Asia Pacific is projected to register the highest growth during the forecast period. This large share can be attributed to factors such as the increasing number of genomic projects and increasing R&D investments by pharmaceutical & biotechnology companies in this region.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type (Supply-side): Tier 1 (29%), Tier 2 (37%), and Tier 3 (34%)
• By Category (Demand-side): Pharmaceutical & Biotechnology Companies (38%), Hospitals & Diagnostic Centers (30%), and Academic &

Government Research Institutes (22%), and Other End Users (10%)
• By Designation: C-level (37%), Director-level (23%), and Managers (40%)
• By Region: North America (37%), Europe (30%), Asia Pacific (21%), and the RoW (12%)

QIAGEN N.V. (Netherlands), Thermo Fisher Scientific (US), and F. Hoffmann-La Roche Ltd. (Switzerland) are the leading players in the global nucleic acid isolation and purification market. Other notable players in this market include Promega Corporation (US), Agilent Technologies (US), Bio-Rad Laboratories (US), Danaher Corporation (US), GE Healthcare (US), Illumina, Inc. (US), Merck KGaA (Germany), Takara Bio (Japan), Zymo Research (US), New England Biolabs (US), Norgen Biotek Corp (Canada), Omega Bio-tek (US), Genaxxon Bioscience GmbH (Germany), 3B BlackBio Biotech India Limited (India), Invitek Molecular (Germany), BioVision (US), and Analytik Jena AG (Germany).
Research Coverage:

The report analyzes the nucleic acid isolation and purification market and aims at estimating the market size and future growth potential of this market based on various segments such as product, method, type, application, end user, and region. The report also includes the competitive analysis of the key players in this market, along with their company profiles, product & service offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the nucleic acid isolation and purification market. The report analyzes the market based on the product, type, application, end user, and region.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the nucleic acid isolation and purification market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of nucleic acid isolation and purification solutions across regions.
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the nucleic acid isolation and purification market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the nucleic acid isolation and purification market.

【レポートの目次】

1 INTRODUCTION (Page No. – 17)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. – 21)
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primary sources
2.2 MARKET SIZE ESTIMATION
2.3 MARKET GROWTH RATE PROJECTIONS
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 MARKET SHARE ESTIMATION
2.6 ASSUMPTIONS FOR THE STUDY
2.7 LIMITATIONS FOR RESEARCH

3 EXECUTIVE SUMMARY (Page No. – 30)

4 PREMIUM INSIGHTS (Page No. – 36)
4.1 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET OVERVIEW
4.2 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT (2019)
4.3 GEOGRAPHICAL SNAPSHOT OF THE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET

5 MARKET OVERVIEW (Page No. – 39)
5.1 MARKET DYNAMICS
5.1.1 DRIVERS
5.1.1.1 Increasing R&D activities
5.1.1.2 Technological advancements and increasing automation
5.1.2 RESTRAINTS
5.1.2.1 High cost of automated instruments
5.1.3 OPPORTUNITIES
5.1.3.1 High scope of growth in emerging economies
5.1.3.2 Improving regulatory and reimbursement scenario
5.1.3.3 Molecular diagnostics and personalized medicine
5.1.4 TRENDS
5.1.4.1 Impact of the COVID-19 pandemic
5.1.4.2 Increase in government funding

6 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT (Page No. – 45)
6.1 INTRODUCTION
6.2 KITS
6.2.1 KITS WERE THE LARGEST PRODUCT SEGMENT IN THE MARKET IN 2019
6.3 REAGENTS
6.3.1 REAGENTS SEGMENT TO GROW AT A STEADY RATE DURING THE FORECAST PERIOD
6.4 INSTRUMENTS
6.4.1 AUTOMATED INSTRUMENTS ENABLE A FASTER, CLEANER, AND MORE CONSISTENT NUCLEIC ACID EXTRACTION PROCESS

7 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD (Page No. – 50)
7.1 INTRODUCTION
7.2 COLUMN-BASED ISOLATION AND PURIFICATION
7.2.1 COLUMN-BASED ISOLATION AND PURIFICATION WAS THE LARGEST SEGMENT IN THE MARKET IN 2019
7.3 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION
7.3.1 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
7.4 REAGENT-BASED ISOLATION AND PURIFICATION
7.4.1 REAGENT-BASED ISOLATION AND PURIFICATION SEGMENT TO REGISTER STEADY GROWTH DURING THE FORECAST PERIOD
7.5 OTHER ISOLATION AND PURIFICATION METHODS

8 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE (Page No. – 55)
8.1 INTRODUCTION
8.2 PLASMID DNA ISOLATION AND PURIFICATION
8.2.1 PLASMID DNA ISOLATION AND PURIFICATION ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET
8.3 TOTAL RNA ISOLATION AND PURIFICATION
8.3.1 TOTAL RNA ISOLATION AND PURIFICATION SEGMENT TO REGISTER STEADY GROWTH
8.4 GENOMIC DNA ISOLATION AND PURIFICATION
8.4.1 GENOMIC DNA ISOLATION IS THE FIRST STEP IN GENETIC-BASED TESTS
8.5 MESSENGER RNA ISOLATION AND PURIFICATION
8.5.1 MESSENGER RNA ISOLATION AND PURIFICATION IS MAINLY USED IN THE STUDY OF GENE EXPRESSION AND TRANSCRIPTOMICS
8.6 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION
8.6.1 CLINICAL APPLICATIONS TO DRIVE THE MARKET FOR CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION
8.7 MICRORNA ISOLATION AND PURIFICATION
8.7.1 MICRORNA KITS PROVIDE RAPID ISOLATION AND PURIFICATION OF RNA MOLECULES FROM SAMPLES
8.8 PCR CLEANUP
8.8.1 TIME-CONSUMING LABORATORY PROCEDURES TO LIMIT THE GROWTH OF THIS MARKET DURING THE FORECAST PERIOD
8.9 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES

9 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION (Page No. – 65)
9.1 INTRODUCTION
9.2 DIAGNOSTICS
9.2.1 DIAGNOSTIC APPLICATIONS FORM THE LARGEST AND FASTEST-GROWING SEGMENT IN THE MARKET
9.3 DRUG DISCOVERY & DEVELOPMENT
9.3.1 NGS BENEFITS DRUG DISCOVERY APPLICATIONS IN VARIOUS THERAPEUTIC AREAS
9.4 PERSONALIZED MEDICINE
9.4.1 RISING INCIDENCE OF CANCER AND INCREASING RESEARCH AND FUNDING TO DRIVE THE MARKET FOR THIS SEGMENT
9.5 AGRICULTURE & ANIMAL RESEARCH
9.5.1 FAVORABLE FUNDING SCENARIO TO SUPPORT MARKET GROWTH
9.6 OTHER APPLICATIONS

10 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER (Page No. – 72)
10.1 INTRODUCTION
10.2 HOSPITALS & DIAGNOSTIC CENTERS
10.2.1 AVAILABILITY OF GENETIC TESTS AND RISING FOCUS ON PERSONALIZED MEDICINE IN HOSPITALS TO DRIVE MARKET GROWTH
10.3 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES
10.3.1 INCREASE IN RESEARCH INTENSITY TO DRIVE THE USAGE OF NUCLEIC ACID ISOLATION AND PURIFICATION SYSTEMS
10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.4.1 INCREASING NUMBER OF RESEARCH PROJECTS IN GENOMICS AND RELATED AREAS IS EXPECTED TO DRIVE THE MARKET
10.5 CONTRACT RESEARCH ORGANIZATIONS
10.5.1 CONTRACT RESEARCH ORGANIZATIONS ARE EXPECTED TO REGISTER STEADY GROWTH DURING THE FORECAST PERIOD
10.6 OTHER END USERS

11 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION (Page No. – 80)
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 US
11.2.1.1 Government and private funding to support market growth in the US
11.2.2 CANADA
11.2.2.1 Demand for nucleic acid isolation and purification in Canada is increasing primarily due to growing investments in genomics
11.3 EUROPE
11.3.1 GERMANY
11.3.1.1 Germany is the largest market for nucleic acid isolation and purification in Europe
11.3.2 UK
11.3.2.1 Government support for research in the form of investments, funds, and grants to support market growth
11.3.3 FRANCE
11.3.3.1 High cancer burden in France to drive market growth
11.3.4 ROE
11.4 ASIA PACIFIC
11.4.1 CHINA
11.4.1.1 China to register the highest growth in the nucleic acid isolation and purification market in APAC
11.4.2 JAPAN
11.4.2.1 Japan to register steady growth during the forecast period
11.4.3 INDIA
11.4.3.1 Strong growth trends in the pharmaceutical & biotechnology industries to drive the market in India
11.4.4 ROAPAC
11.5 REST OF THE WORLD
11.5.1 LATIN AMERICA
11.5.1.1 To prevent cancer mortality, the Brazilian government recommends screening programs for breast and prostate cancer
11.5.2 MIDDLE EAST & AFRICA
11.5.2.1 Lack of infrastructure for research to hamper the growth of the NAIP market in the Middle East & Africa

12 COMPETITIVE LANDSCAPE (Page No. – 132)
12.1 INTRODUCTION
12.2 MARKET EVALUATION FRAMEWORK
12.3 REVENUE ANALYSIS OF TOP MARKET PLAYERS
12.4 COMPETITIVE SCENARIO
12.4.1 COLLABORATIONS & AGREEMENTS
12.4.2 PRODUCT LAUNCHES & APPROVALS
12.4.3 ACQUISITIONS
12.4.4 EXPANSIONS

13 COMPANY EVALUATION MATRIX AND COMPANY PROFILES (Page No. – 136)
13.1 COMPANY EVALUATION MATRIX
13.1.1 MARKET SHARE ANALYSIS
13.2 COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET) (2019)
13.2.1 STARS
13.2.2 EMERGING LEADERS
13.2.3 PERVASIVE PLAYERS
13.2.4 EMERGING COMPANIES

14 COMPANY PROFILES (Page No. – 139)
(Business Overview, Products Offered, Recent Developments, MnM View)*
14.1 QIAGEN N.V.
14.2 THERMO FISHER SCIENTIFIC
14.3 F. HOFFMAN-LA ROCHE AG
14.4 PROMEGA CORPORATION
14.5 AGILENT TECHNOLOGIES
14.6 BIO-RAD LABORATORIES
14.7 DANAHER CORPORATION
14.8 GE HEALTHCARE
14.9 ILLUMINA
14.10 MERCK KGAA
14.11 TAKARA BIO, INC.
14.12 NEW ENGLAND BIOLABS
14.13 ZYMO RESEARCH
14.14 NORGEN BIOTEK
14.15 OMEGA BIO-TEK, INC.
14.16 OTHER COMPANIES
14.16.1 GENAXXON BIOSCIENCE GMBH
14.16.2 3B BLACKBIO BIOTECH INDIA LTD.
14.16.3 INVITEK MOLECULAR GMBH
14.16.4 BIOVISION
14.16.5 ANALYTIK JENA AG

*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.



★調査レポート[核酸分離・精製の世界市場予測(~2025):製品別、方法別、種類別、用途別、エンドユーザー別] ( Nucleic Acid Isolation and Purification Market by Product (Kit, Reagent, Instrument), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, miRNA), Application (Drug Discovery, Precision Medicine), End User (Academic) - Global Forecast to 2025 / BT 2398) 販売に関する免責事項
[核酸分離・精製の世界市場予測(~2025):製品別、方法別、種類別、用途別、エンドユーザー別] ( Nucleic Acid Isolation and Purification Market by Product (Kit, Reagent, Instrument), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, miRNA), Application (Drug Discovery, Precision Medicine), End User (Academic) - Global Forecast to 2025 / BT 2398) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆